ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,635Medicare Part D Prescriptions Filled, Including Refills

Rank: 273 out of 6645

$1.03M Total Retail Price of All Prescriptions

Rank: 302 out of 6645

927 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 927 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 927 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 14,827 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 707 642 1 1
LEVOTHYROXINE SODIUM 618 576 2 4
LISINOPRIL 561 544 3 3
HYDROCODONE-ACETAMINOPHEN 483 377 S3 4 5
FUROSEMIDE 463 435 5 11
METOPROLOL TARTRATE 402 391 6 13
WARFARIN SODIUM 332 293 7 16
LOVASTATIN 331 316 8 15
OMEPRAZOLE 328 298 9 6
POTASSIUM CHLORIDE 325 280 10 28
ATENOLOL 321 294 11 8
AMLODIPINE BESYLATE 320 314 12 2
METFORMIN HCL 297 268 13 7
GABAPENTIN 291 261 14 18
PRAVASTATIN SODIUM 276 263 15 20
TRIAMTERENE-HCTZ 226 215 16 52
DONEPEZIL HCL 223 223 17 27
LOSARTAN POTASSIUM 211 199 18 12
CIPROFLOXACIN HCL 203 191 19 67
ZOLPIDEM TARTRATE 189 170 20 17
PREDNISONE 183 168 21 57
RANITIDINE HCL 180 168 22 51
SERTRALINE HCL 173 156 23 43
CLOPIDOGREL 168 161 24 36
HYDROCHLOROTHIAZIDE 162 152 25 9
DIGOXIN 162 157 25 59
FINASTERIDE 152 137 27 73
BISOPROLOL-HYDROCHLOROTHIAZIDE 136 134 28 339
FELODIPINE ER 136 123 28 105
HYDROXYZINE HCL 133 117 R 30 161
TERAZOSIN HCL 126 126 31 48
DOXAZOSIN MESYLATE 121 121 32 81
CARVEDILOL 121 116 32 25
GLYBURIDE 119 113 R 34 58
TAMSULOSIN HCL 118 105 35 22
ATORVASTATIN CALCIUM 113 110 36 10
ALLOPURINOL 109 90 37 31
BENAZEPRIL HCL 106 97 38 21
PLAVIX 105 98 39 49
PROAIR HFA 103 87 40 32
CITALOPRAM HBR 100 90 41 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 94 41 37
CARISOPRODOL 99 56 R 43 94
FLUTICASONE PROPIONATE 99 78 43 26
TRAMADOL HCL 98 81 45 30
FLUOXETINE HCL 98 72 45 63
CEPHALEXIN 98 88 45 111
PANTOPRAZOLE SODIUM 98 94 45 29
ALENDRONATE SODIUM 97 97 49 14
TRAZODONE HCL 94 66 50 60
TRIAMTERENE-HYDROCHLOROTHIAZID 94 80 50 143
NEXIUM 87 76 52 40
DIOVAN 79 79 53 19
KLOR-CON 10 78 77 54 145
ENALAPRIL MALEATE 78 56 54 75
PREMARIN 77 45 R 56 169
GLIPIZIDE 77 70 56 23
OXYBUTYNIN CHLORIDE 77 77 56 129
AZITHROMYCIN 75 71 59 44
FENOFIBRATE 70 68 60 74
NAMENDA 69 69 61 41
LEVOXYL 69 66 61 136
SPIRONOLACTONE 68 66 63 85
MEGESTROL ACETATE 66 54 R 64 104
ADVAIR DISKUS 64 52 65 45
LABETALOL HCL 63 60 66 226
GEMFIBROZIL 61 60 67 96
INSULIN SYRINGE 60 42 68 61
SPIRIVA 60 47 68 65
NITROGLYCERIN PATCH 60 57 68 304
NITROFURANTOIN MONO-MACRO 59 56 71 233
ACTONEL 59 58 71 92
ZOSTAVAX 57 53 73 115
PROPRANOLOL HCL 56 53 74 151
SYNTHROID 53 39 75 79
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 50 75 134
ACETAMINOPHEN-CODEINE 53 51 S3 75 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.